Cargando…

Smartphone-Based Chemiluminescent Origami µPAD for the Rapid Assessment of Glucose Blood Levels

Microfluidic paper analytical devices (µPADs) represent one of the most appealing trends in the development of simple and inexpensive analytical systems for diagnostic applications at the point of care (POC). Herein, we describe a smartphone-based origami µPAD for the quantitative determination of g...

Descripción completa

Detalles Bibliográficos
Autores principales: Calabria, Donato, Zangheri, Martina, Trozzi, Ilaria, Lazzarini, Elisa, Pace, Andrea, Mirasoli, Mara, Guardigli, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533763/
https://www.ncbi.nlm.nih.gov/pubmed/34677337
http://dx.doi.org/10.3390/bios11100381
_version_ 1784587391799918592
author Calabria, Donato
Zangheri, Martina
Trozzi, Ilaria
Lazzarini, Elisa
Pace, Andrea
Mirasoli, Mara
Guardigli, Massimo
author_facet Calabria, Donato
Zangheri, Martina
Trozzi, Ilaria
Lazzarini, Elisa
Pace, Andrea
Mirasoli, Mara
Guardigli, Massimo
author_sort Calabria, Donato
collection PubMed
description Microfluidic paper analytical devices (µPADs) represent one of the most appealing trends in the development of simple and inexpensive analytical systems for diagnostic applications at the point of care (POC). Herein, we describe a smartphone-based origami µPAD for the quantitative determination of glucose in blood samples based on the glucose oxidase-catalyzed oxidation of glucose leading to hydrogen peroxide, which is then detected by means of the luminol/hexacyanoferrate(III) chemiluminescent (CL) system. By exploiting the foldable µPAD format, a two-step analytical procedure has been implemented. First, the diluted blood sample was added, and hydrogen peroxide was accumulated, then the biosensor was folded, and a transport buffer was added to bring hydrogen peroxide in contact with CL reagents, thus promoting the CL reaction. To enable POC applicability, the reagents required for the assay were preloaded in the µPAD so that no chemicals handling was required, and a 3D-printed portable device was developed for measuring the CL emission using the smartphone’s CMOS camera. The µPAD was stable for 30-day storage at room temperature and the assay, displaying a limit of detection of 10 µmol L(−1), proved able to identify both hypoglycemic and hyperglycemic blood samples in less than 20 min.
format Online
Article
Text
id pubmed-8533763
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85337632021-10-23 Smartphone-Based Chemiluminescent Origami µPAD for the Rapid Assessment of Glucose Blood Levels Calabria, Donato Zangheri, Martina Trozzi, Ilaria Lazzarini, Elisa Pace, Andrea Mirasoli, Mara Guardigli, Massimo Biosensors (Basel) Article Microfluidic paper analytical devices (µPADs) represent one of the most appealing trends in the development of simple and inexpensive analytical systems for diagnostic applications at the point of care (POC). Herein, we describe a smartphone-based origami µPAD for the quantitative determination of glucose in blood samples based on the glucose oxidase-catalyzed oxidation of glucose leading to hydrogen peroxide, which is then detected by means of the luminol/hexacyanoferrate(III) chemiluminescent (CL) system. By exploiting the foldable µPAD format, a two-step analytical procedure has been implemented. First, the diluted blood sample was added, and hydrogen peroxide was accumulated, then the biosensor was folded, and a transport buffer was added to bring hydrogen peroxide in contact with CL reagents, thus promoting the CL reaction. To enable POC applicability, the reagents required for the assay were preloaded in the µPAD so that no chemicals handling was required, and a 3D-printed portable device was developed for measuring the CL emission using the smartphone’s CMOS camera. The µPAD was stable for 30-day storage at room temperature and the assay, displaying a limit of detection of 10 µmol L(−1), proved able to identify both hypoglycemic and hyperglycemic blood samples in less than 20 min. MDPI 2021-10-09 /pmc/articles/PMC8533763/ /pubmed/34677337 http://dx.doi.org/10.3390/bios11100381 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Calabria, Donato
Zangheri, Martina
Trozzi, Ilaria
Lazzarini, Elisa
Pace, Andrea
Mirasoli, Mara
Guardigli, Massimo
Smartphone-Based Chemiluminescent Origami µPAD for the Rapid Assessment of Glucose Blood Levels
title Smartphone-Based Chemiluminescent Origami µPAD for the Rapid Assessment of Glucose Blood Levels
title_full Smartphone-Based Chemiluminescent Origami µPAD for the Rapid Assessment of Glucose Blood Levels
title_fullStr Smartphone-Based Chemiluminescent Origami µPAD for the Rapid Assessment of Glucose Blood Levels
title_full_unstemmed Smartphone-Based Chemiluminescent Origami µPAD for the Rapid Assessment of Glucose Blood Levels
title_short Smartphone-Based Chemiluminescent Origami µPAD for the Rapid Assessment of Glucose Blood Levels
title_sort smartphone-based chemiluminescent origami µpad for the rapid assessment of glucose blood levels
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533763/
https://www.ncbi.nlm.nih.gov/pubmed/34677337
http://dx.doi.org/10.3390/bios11100381
work_keys_str_mv AT calabriadonato smartphonebasedchemiluminescentorigamiμpadfortherapidassessmentofglucosebloodlevels
AT zangherimartina smartphonebasedchemiluminescentorigamiμpadfortherapidassessmentofglucosebloodlevels
AT trozziilaria smartphonebasedchemiluminescentorigamiμpadfortherapidassessmentofglucosebloodlevels
AT lazzarinielisa smartphonebasedchemiluminescentorigamiμpadfortherapidassessmentofglucosebloodlevels
AT paceandrea smartphonebasedchemiluminescentorigamiμpadfortherapidassessmentofglucosebloodlevels
AT mirasolimara smartphonebasedchemiluminescentorigamiμpadfortherapidassessmentofglucosebloodlevels
AT guardiglimassimo smartphonebasedchemiluminescentorigamiμpadfortherapidassessmentofglucosebloodlevels